CEHD <4320.T> rebounded, reaching 661 yen, up 55 yen at one point. After the close on February 28, a revision of the consolidated financial estimates for the second quarter cumulative of the fiscal year ending September 2025 (October 2024 - March 2025) was positively received.
In the performance estimates for the second quarter cumulative, the revenue was revised upward from 8.1 billion yen to 9.2 billion yen (an increase of 14.0% year-on-year), and the operating profit was increased from 780 million yen to 1.1 billion yen (an increase of 48.4% year-on-year). This is due to an increase in orders for the company's core product, the electronic medical record system 'MI_RA_Is series', and the incorporation of sales that were recorded ahead of schedule for various projects that were originally planned for the third quarter (April - June).
As of 12:43 PM, the stock price was 626 yen, up 20 yen from the previous weekend.
Provided by Wealth Advisor Company.
Comment(0)
Reason For Report